Endomicroscopy, IBS and Food Intolerance
Launched by UNIVERSITY HOSPITAL SCHLESWIG-HOLSTEIN · Sep 20, 2012
Trial Information
Current as of May 20, 2025
Completed
Keywords
ClinConnect Summary
The primary endpoint is the visible marked increase of lymphocytes and mononuclear cells in the lamina propria of the duodenum, representing an acute reaction to one of the allergens sprayed to its surface through the endoscope channel.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age \> 18 years
- • ongoing abdominal symptoms such as bloating and abdominal pain
- • negative routine testing for food intolerance (or known lactose/fructose intolerance)
- • written informed consent
- Exclusion Criteria:
- • no consent
- • known reason for the abdominal pain and bloating other than lactose/fructose intolerance
- • M. Whipple
- • known infectious gastrointestinal disease
- • stricture in the upper gastrointestinal tract
- • age \>18years
- • impaired renal function (Creatinine \>1.2 mg/dL)
- • pregnancy or breast feeding
- • inability to obtain informed consent
- • active GI Bleeding
- • known allergy to Methylene blue or Fluorescein
- • participation in other clinical trials within the last 4 weeks
About University Hospital Schleswig Holstein
University Hospital Schleswig-Holstein (UKSH) is a leading academic medical center in Germany, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent institution, UKSH integrates cutting-edge medical research with comprehensive patient care, fostering an environment that promotes the development of novel therapeutic strategies. With a multidisciplinary approach and a strong emphasis on collaboration, UKSH is dedicated to enhancing clinical outcomes and contributing to the global medical community through rigorous scientific inquiry and the translation of research findings into practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kiel, , Germany
Patients applied
Trial Officials
Annette Fritscher-Ravens, Prof. Dr.
Principal Investigator
University Schleswig-Holstein
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials